Mark Neumann - 03 Feb 2026 Form 3 Insider Report for Veradermics, Inc (MANE)

Role: Chief Commercial Officer, Strategy Officer
Signature: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol: MANE
Transactions as of: 03 Feb 2026
Net transactions value: $0
Form type: 3
Filing time: 03 Feb 2026, 21:05:25 UTC
Previous filing: 02 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Neumann Mark	Chief Commercial Officer, Strategy Officer	C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN	/s/ Michael Greco, Attorney-in-Fact	03 Feb 2026	0001756211

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MANE	Stock Option (Right to Buy)							03 Feb 2026	Common Stock	264,206	$12.79	Direct	F1
holding	MANE	Stock Option (Right to Buy)							03 Feb 2026	Common Stock	39,630	$12.79	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on December 12, 2026, the first anniversary of the vesting commencement date, and vests as to the remaining shares in equal monthly installments over 36 months thereafter, subject to continued service.
F2	This option shall be fully vested and exercisable upon the certification by the Issuer's board of directors (or compensation committee thereof) that the Issuer has achieved a market capitalization of $680.0 million prior to December 31, 2026, subject to the reporting person's continued service. Market capitalization will be measured as the trading price per share of the Issuer's Common Stock on its principal market national stock exchange multiplied by the number of the Issuer's shares of Common Stock issued and outstanding.

Content

The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on December 12, 2026, the first anniversary of the vesting commencement date, and vests as to the remaining shares in equal monthly installments over 36 months thereafter, subject to continued service.

This option shall be fully vested and exercisable upon the certification by the Issuer's board of directors (or compensation committee thereof) that the Issuer has achieved a market capitalization of $680.0 million prior to December 31, 2026, subject to the reporting person's continued service. Market capitalization will be measured as the trading price per share of the Issuer's Common Stock on its principal market national stock exchange multiplied by the number of the Issuer's shares of Common Stock issued and outstanding.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney